Skip to main content
In stock | Cytotoxic Chemotherapy

Namitecan

Oncology Type Both (Solid & Hematologic)
Drug Class / Mechanism Topoisomerase Inhibitor
No Image
Description

Namitecan is classified as a Topoisomerase Inhibitor, sourced for use within our Cytotoxic Chemotherapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Cytotoxic Chemotherapy
Oncology Type Both (Solid & Hematologic)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3